遗传性结肠直肠癌的进展:精准医学是如何改变游戏的
Shenghao Lin1, Chenxi Zhou1, Hanlin Chen1
1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, China.
Cancers
|November 13, 2025
概括
遗传性结直肠癌 (HCRC) 管理正在通过精准医学取得进展. 查,治疗和人工智能驱动的诊断方面的创新为更好的患者结果提供了量身定制的护理.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 生物信息学是一种生物信息学.
- 医疗成像医学成像
背景情况:
- 遗传性结肠直肠癌 (HCRC) 占~5%的病例,经常出现早期发病和家族聚合.
- 公共意识不足导致诊断迟到,缺少HCRC的最佳治疗窗口.
- 目前的管理需要在早期检测,向治疗和个性化后续策略方面取得进展.
研究的目的:
- 审查HCRC的精确查,治疗,评估和预防方面的最新进展.
- 突出人工智能 (AI) 和新技术在管理HCRC中的作用.
- 讨论量身定制的护理策略的潜力,以优化HCRC患者的治疗结果.
主要方法:
- 基因组,转录组和微生物组分析用于临床前检测突变和危险因素.
- 人工智能与内镜和成像工具的集成,用于增强多检测和瘤分析.
- 液体活检和分子标记物检测用于非侵入性监测.
- 对免疫治疗 (例如dMMR检查点抑制剂) 和向治疗 (例如KRAS,BRAF V600E突变) 的审查.
主要成果:
- 精确的查方法有效地在临床前识别病原突变和"促进癌症"的环境.
- 人工智能提高了多体检测和瘤特征的诊断准确度.
- 非侵入性监测解决方案正在通过液体活检和分子标记物出现.
- 精确治疗策略,包括免疫疗法和向治疗,对特定的HCRC亚型有希望.
结论:
- 精准医学正在彻底改变HCRC的临床管理,使得量身定制的护理成为可能.
- 人工智能,先进诊断和多omics方法是优化HCRC查,治疗和随访的关键.
- 综合数据分析有助于复发风险评估和个性化患者管理,改善整体结果.
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K


